| Literature DB >> 35284660 |
Bachti Alisjahbana1,2, Nuni Sulastri3, Resvi Livia4, Lika Apriani2,5, Ayesha J Verrall6, Edhyana Sahiratmadja7.
Abstract
Background: Matrix metalloproteinase (MMP) activity has an important role in lung cavitary formation occurred in pulmonary tuberculosis (TB). Low number and viability of CD4 + T-lymphocytes in patients with TB/HIV co-infection leads to impaired neutrophils production, causing further impaired MMPs production. Objective: To explore association of neutrophils and lymphocytes count to MMP-8 and MMP-9 among pulmonary TB patients with cavitary lesion and HIV co-infection.Entities:
Keywords: Cavity; Human immunodeficiency viruses; Lymphocyte; MMP; Neutrophil; Tuberculosis
Year: 2022 PMID: 35284660 PMCID: PMC8913355 DOI: 10.1016/j.jctube.2022.100308
Source DB: PubMed Journal: J Clin Tuberc Other Mycobact Dis ISSN: 2405-5794
Characteristic, clinical symptoms and radiographic findings among new pulmonary tuberculosis patients with no cavity, with cavity and with HIV co-infection.
| TB | TB/HIV ( | ||||||
|---|---|---|---|---|---|---|---|
| Non Cavitary ( | Cavitary ( | ||||||
| % | % | % | |||||
| Gender | |||||||
| Male | 25 | 50.0 | 29 | 57.9 | 18 | 66.6 | 0.36 |
| Female | 25 | 50.0 | 21 | 42.0 | 9 | 33.3 | |
| Age | |||||||
| 18–29 | 19 | 38.0 | 19 | 38.0 | 13 | 48.1 | 0.195 |
| 30–50 | 21 | 42.0 | 23 | 46.0 | 14 | 51.8 | |
| >50 | 10 | 20.0 | 8 | 16.0 | 0 | 0.0 | |
| Weight | |||||||
| loss of weight * | |||||||
| <5kg | 36 | 72.0 | 31 | 62.0 | 11 | 40.7 | |
| >5kg | 14 | 28.0 | 19 | 38.0 | 16 | 59.2 | |
| BMI category (kg/m2) | |||||||
| <18.5 | 24 | 48.0 | 30 | 60.0 | 22 | 81.4 | |
| ≥18.5 | 26 | 52.0 | 20 | 40.0 | 5 | 18.5 | |
| Cough duration | |||||||
| ≤2 weeks | 4 | 8.0 | 2 | 4.0 | 10 | 37.0 | |
| ≥3 weeks * | 46 | 92.0 | 48 | 96.0 | 17 | 62.9 | |
| Haemoptysis | |||||||
| No | 30 | 60.0 | 29 | 57.9 | 22 | 81.4 | |
| Mild Haemoptysis | 10 | 20.0 | 4 | 8.0 | 4 | 14.8 | |
| Massive Haemoptysis | 10 | 20.0 | 17 | 34.0 | 1 | 3.70 | |
| Dyspnea | |||||||
| Yes | 29 | 57.9 | 34 | 68.0 | 18 | 66.6 | 0.55 |
| No | 21 | 42.0 | 16 | 32.0 | 9 | 33.3 | |
| Night sweat * | |||||||
| Yes | 41 | 82.0 | 45 | 90.0 | 15 | 55.5 | |
| No | 9 | 18.0 | 5 | 10.0 | 12 | 44.4 | |
| Bacteriology confirmation | |||||||
| Sputum AFB | |||||||
| Positive | 46 | 92.0 | 50.0 | 100 | 20 | 74.0 | |
| Negative | 4 | 8.0 | 0 | 0 | 7 | 25.9 | |
| Mtb Culture | |||||||
| Positive | 45 | 90.0 | 48 | 96.0 | 13 | 48 | |
| Negative | 2 | 4 | 0 | 0 | 10 | 37 | |
| Xpert Mtb pos | 6 | 12.0 | 7 | 25.0 | NA | NA | NA* |
| Consolidation | |||||||
| Any | 23 | 18.1 | 19 | 15 | 4 | 3.1 | |
| None | 27 | 21.3 | 31 | 24.4 | 23 | 18.1 | |
| Pleural effusion | |||||||
| Yes | 5 | 3.9 | 5 | 3.9 | 2 | 1.6 | 0.99 |
| No | 45 | 35.4 | 45 | 35.4 | 16 | 12.6 | |
| % of visible lung affected | |||||||
| <30% | 15 | 11.8 | 14 | 11 | 10 | 7.9 | 0.067β |
| 30–60% | 21 | 16.5 | 20 | 15.7 | 13 | 10.2 | |
| ≥ 60% | 14 | 11.0 | 16 | 12.6 | 4 | 3.1 | |
*Clinical symptom occurred in >75% of new pulmonary tuberculosis patients. p values were calculated using Chi-square test. Βp values were calculated using Kruskal-Wallis test *was significant p-values. NA, Not available. NA*, Not Applicable; BMI, body mass index; HIV, human immunodeficiency virus; TB, tuberculosis.
The level of neutrophils, lymphocytes, MMP-8 and MMP-9 among patients with non-cavitary TB, cavitary TB and TB/HIV co-infection.
| TB | All TB (N = 100) | TB/HIV (N = 27) | Pa | Pb | Pc | ||
|---|---|---|---|---|---|---|---|
| Non Cavitary (N = 50) | Cavitary (N = 50) | ||||||
| Neutrophil (x103/μL) | 6.61 ± 1.40 | 8.27 ± 1.45 | 7.4 ± 1.45 | 5.14 ± 2.19 | |||
| lymphocyte (x103/μL) | 1.63 ± 0.66 | 1.51 ± 0.61 | 1.57 ± 0.64 | 1.02 ± 0.57 | 0.344 | ||
| MMP-8 (pg/mL) | 1178.28 ± 2.69 | 2630.27 ± 2.95 | 2137.96 ± 2.88 | 4677.35 ± 3.89 | 0.065 | ||
| MMP-9 (pg/mL) | 48977.88 ± 1.95 | 63095.73 ± 2.04 | 54954.09 ± 2.00 | 30902.95 ± 2.63 | 0.052 | ||
Note. The value presented as geometric mean ± SD. *significant p-values.
Pa = TB with and without cavity; Pb = all TB and TB/HIV; Pc = TB with and without cavity and TB/HIV. MMP, Matrix Metalloproteinase; HIV, human immunodeficiency virus; TB, tuberculosis.
Fig. 1Significant positive correlation between neutrophils and MMP-8 among TB patients with no cavity, with cavity and TB/HIV co-infection. MMP, Matrix Metalloproteinase; HIV, human immunodeficiency virus; TB, tuberculosis.
Fig. 2Significant positive relation between neutrophils and MMP-9 among TB patients with no cavity, with cavity and TB/HIV co-infection MMP, Matrix Metalloproteinase; HIV, human immunodeficiency virus; TB, tuberculosis.
Fig. 3Significant negative correlation between lymphocyte and MMP-8 among TB with cavity and non-cavitary TB, but no in TB/HIV co-infection. MMP, Matrix Metalloproteinase; HIV, human immunodeficiency virus; TB, tuberculosis.
Fig. 4In pulmonary TB with cavity, neutrophil (**p < 0.01) and MMP-8 (*p < 0.05) were significantly increased among patient with >60% of visible lung affected, however, MMP-9 was not significant. MMP, Matrix Metalloproteinase; TB, tuberculosis.